Peter J Gilbar

964 total citations
61 papers, 579 citations indexed

About

Peter J Gilbar is a scholar working on Oncology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Peter J Gilbar has authored 61 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Dermatology and 12 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Peter J Gilbar's work include Cancer Treatment and Pharmacology (13 papers), Chemotherapy-related skin toxicity (12 papers) and Safe Handling of Antineoplastic Drugs (10 papers). Peter J Gilbar is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Chemotherapy-related skin toxicity (12 papers) and Safe Handling of Antineoplastic Drugs (10 papers). Peter J Gilbar collaborates with scholars based in Australia, Canada and United States. Peter J Gilbar's co-authors include Aimee E. Sullivan, Carole Chambers, Colin Curtain, Michael Dooley, John R. Wood, Andrew Lee, Srinivas Kondalsamy‐Chennakesavan, Brendan Wisniowski, Andrew C. Seger and P.J.M. Sessink and has published in prestigious journals such as Immunity, Nature Reviews Clinical Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Peter J Gilbar

60 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J Gilbar Australia 14 190 115 103 72 60 61 579
Jane M. Pruemer United States 10 91 0.5× 57 0.5× 17 0.2× 35 0.5× 41 0.7× 22 353
Greg Carney Canada 12 75 0.4× 36 0.3× 47 0.5× 45 0.6× 71 1.2× 37 620
Susan Knox United Kingdom 8 115 0.6× 64 0.6× 14 0.1× 65 0.9× 108 1.8× 20 646
Bradley S. Stolshek United States 16 266 1.4× 73 0.6× 46 0.4× 116 1.6× 58 1.0× 44 753
Nicola Ielapi Italy 17 90 0.5× 18 0.2× 26 0.3× 275 3.8× 34 0.6× 67 847
Milica Milakovic Canada 12 93 0.5× 107 0.9× 39 0.4× 170 2.4× 93 1.6× 19 507
Ralph Didlake United States 13 29 0.2× 62 0.5× 16 0.2× 163 2.3× 66 1.1× 36 563
Marisa A. Bittoni United States 15 452 2.4× 67 0.6× 9 0.1× 69 1.0× 83 1.4× 37 868
Sayaka Sasaoka Japan 13 76 0.4× 55 0.5× 26 0.3× 27 0.4× 35 0.6× 24 512
Jocelyn M. Weiss United States 15 129 0.7× 63 0.5× 41 0.4× 297 4.1× 93 1.6× 24 1.1k

Countries citing papers authored by Peter J Gilbar

Since Specialization
Citations

This map shows the geographic impact of Peter J Gilbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J Gilbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J Gilbar more than expected).

Fields of papers citing papers by Peter J Gilbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J Gilbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J Gilbar. The network helps show where Peter J Gilbar may publish in the future.

Co-authorship network of co-authors of Peter J Gilbar

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J Gilbar. A scholar is included among the top collaborators of Peter J Gilbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J Gilbar. Peter J Gilbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbar, Peter J, et al.. (2022). Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab. Journal of Oncology Pharmacy Practice. 28(6). 1450–1453. 11 indexed citations
2.
Hurvitz, Sara A., et al.. (2021). Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer. Breast Cancer Research and Treatment. 190(3). 357–372. 4 indexed citations
3.
Gilbar, Peter J. (2017). A further strategy to combat the high price of anticancer drugs. Nature Reviews Clinical Oncology. 14(10). 629–629. 2 indexed citations
4.
Gilbar, Peter J, et al.. (2015). Immediate and Delayed Hypersensitivity Reactions to a Single Dose of Oxaliplatin. Clinical Colorectal Cancer. 14(2). 128–130. 6 indexed citations
5.
Gilbar, Peter J, et al.. (2015). Small-Cell Lung Cancer in a Young, Female, Never-Smoker. 4(4). 159–162. 2 indexed citations
6.
Gilbar, Peter J. (2013). Intrathecal Chemotherapy. Cancer Nursing. 37(4). 299–309. 10 indexed citations
7.
Gilbar, Peter J, et al.. (2012). Syndrome of Inappropriate Antidiuretic Hormone Secretion Induced by a Single Dose of Oral Cyclophosphamide. Annals of Pharmacotherapy. 46(9). e23–e23. 21 indexed citations
8.
Gilbar, Peter J, et al.. (2004). Inadvertent intrathecal administration of vincristine [6]. Journal of Pharmacy Practice and Research. 34(2). 2 indexed citations
9.
Gilbar, Peter J, et al.. (2004). Inappropriate labelling of patients as opioid allergic. Journal of Oncology Pharmacy Practice. 10(3). 177–182. 14 indexed citations
10.
Gilbar, Peter J, et al.. (2004). Preventing intrathecal administration of vincristine. The Medical Journal of Australia. 181(8). 464–464. 15 indexed citations
11.
Brown, Leanne, et al.. (2002). Chemotherapy nursing practice in rural and remote areas of Queensland. Queensland's institutional digital repository (The University of Queensland). 3(1). 4–12. 1 indexed citations
12.
Brown, Leanne, et al.. (2002). The Chemotherapy Education Needs of Nurses Working in Rural and Remote Areas of Queensland. Immunity. 53(3). 1–16. 1 indexed citations
13.
Gilbar, Peter J. (2002). Palmar‐Plantar Erythrodysaesthesia Associated with an Initial Course of Bolus Fluorouracil. Journal of Pharmacy Practice and Research. 32(3). 178–179. 1 indexed citations
14.
Gilbar, Peter J, et al.. (2002). Dexamethasone prophylaxis for paclitaxel hypersensitivity. Journal of Oncology Pharmacy Practice. 8(2-3). 81–87. 4 indexed citations
15.
Gilbar, Peter J, et al.. (2001). Fall‐Related Hospital Admissions in Elderly Patients: Contribution of Medication Use. The Australian Journal of Hospital Pharmacy. 31(3). 183–187. 1 indexed citations
16.
Gilbar, Peter J. (2001). PREVENTING MEDICATION ERRORS IN CANCER CHEMOTHERAPY REFERRED TO RURAL AND REMOTE HOSPITALS. Australian Journal of Rural Health. 9(1). 47–51. 8 indexed citations
17.
Gilbar, Peter J. (1999). Cancer Chemotherapy: Potential Errors with External Referrals. The Australian Journal of Hospital Pharmacy. 29(2). 100–102. 5 indexed citations
18.
Gilbar, Peter J, et al.. (1999). A Guide to Enteral Drug Administration in Palliative Care. Journal of Pain and Symptom Management. 17(3). 197–207. 37 indexed citations
19.
Gilbar, Peter J, et al.. (1997). Guidelines for Drug Administration During Enteral Feeding. The Australian Journal of Hospital Pharmacy. 27(3). 214–220. 2 indexed citations
20.
Gilbar, Peter J, et al.. (1994). Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix®) with selected drugs during simulated Y-site injection. Queensland's institutional digital repository (The University of Queensland). 24(2). 167–170. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane M. Pruemer Breakdown of academic impact, for papers by Greg Carney Breakdown of academic impact, for papers by Susan Knox Breakdown of academic impact, for papers by Bradley S. Stolshek Breakdown of academic impact, for papers by Nicola Ielapi Breakdown of academic impact, for papers by Milica Milakovic Breakdown of academic impact, for papers by Ralph Didlake Breakdown of academic impact, for papers by Marisa A. Bittoni Breakdown of academic impact, for papers by Sayaka Sasaoka Breakdown of academic impact, for papers by Jocelyn M. Weiss
Rankless by CCL
2026